Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 25 | $1,431,759 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 04 Mar 2025 17:05 | AKBA | Akebia Therapeutics Inc | BUTLER JOHN P. | CEO and President | 03 Mar 2025 | Sale | 46,409 | 1.83 | 84,928 | D |
| 04 Mar 2025 17:04 | AKBA | Akebia Therapeutics Inc | BURKE STEVEN KEITH | SVP, Chief Medical Officer | 03 Mar 2025 | Sale | 7,144 | 1.83 | 13,074 | D |
| 04 Feb 2025 17:54 | AKBA | Akebia Therapeutics Inc | BUTLER JOHN P. | CEO and President | 03 Feb 2025 | Sale | 46,268 | 2.1 | 97,163 | D |
| 04 Feb 2025 17:54 | AKBA | Akebia Therapeutics Inc | BUTLER JOHN P. | CEO and President | 03 Feb 2025 | Sale | 97,982 | 2.1 | 205,762 | D |
| 04 Feb 2025 17:53 | AKBA | Akebia Therapeutics Inc | BURKE STEVEN KEITH | SVP, Chief Medical Officer | 03 Feb 2025 | Sale | 23,270 | 2.1 | 48,867 | D |
| 04 Feb 2025 17:53 | AKBA | Akebia Therapeutics Inc | BURKE STEVEN KEITH | SVP, Chief Medical Officer | 03 Feb 2025 | Sale | 27,236 | 2.1 | 57,196 | D |
| 04 Feb 2025 17:52 | AKBA | Akebia Therapeutics Inc | MALABRE RICHARD C | SVP, Chief Accounting Officer | 03 Feb 2025 | Sale | 30,202 | 2.1 | 63,424 | D |
| 04 Feb 2025 17:51 | AKBA | Akebia Therapeutics Inc | GRUND NICHOLAS | Chief Commercial Officer | 03 Feb 2025 | Sale | 55,621 | 2.1 | 116,804 | D |
| 14 May 2024 16:05 | AKBA | Akebia Therapeutics Inc | HADAS NICOLE R. | SVP, Chief Legal Officer | 13 May 2024 | Sale | 12,016 | 1.26 | 15,140 | D |
| 14 May 2024 16:04 | AKBA | Akebia Therapeutics Inc | DAHAN MICHEL | SVP, Chief Operating Officer | 13 May 2024 | Sale | 34,840 | 1.26 | 43,898 | D |
| 09 May 2024 17:27 | AKBA | Akebia Therapeutics Inc | BURKE STEVEN KEITH | SVP, Chief Medical Officer | 25 Aug 2023 | Sale | 27,000 | 1.15 | 31,050 | D |
| 01 Mar 2024 17:49 | AKBA | Akebia Therapeutics Inc | DAHAN MICHEL | SVP, Chief Operating Officer | 29 Feb 2024 | Sale | 8,661 | 1.58 | 13,684 | D |
| 01 Mar 2024 17:48 | AKBA | Akebia Therapeutics Inc | HADAS NICOLE R. | SVP, Chief Legal Officer | 29 Feb 2024 | Sale | 5,974 | 1.58 | 9,439 | D |
| 01 Mar 2024 17:47 | AKBA | Akebia Therapeutics Inc | BUTLER JOHN P. | CEO and President | 29 Feb 2024 | Sale | 46,570 | 1.58 | 73,581 | D |
| 01 Mar 2024 17:46 | AKBA | Akebia Therapeutics Inc | BURKE STEVEN KEITH | SVP, Chief Medical Officer | 29 Feb 2024 | Sale | 7,169 | 1.58 | 11,327 | D |
| 29 Feb 2024 18:03 | AKBA | Akebia Therapeutics Inc | HADAS NICOLE R. | SVP, Chief Legal Officer | 27 Feb 2024 | Sale | 7,411 | 1.52 | 11,265 | D |
| 29 Feb 2024 18:02 | AKBA | Akebia Therapeutics Inc | DAHAN MICHEL | SVP, Chief Operating Officer | 27 Feb 2024 | Sale | 10,744 | 1.52 | 16,331 | D |
| 29 Feb 2024 18:01 | AKBA | Akebia Therapeutics Inc | BURKE STEVEN KEITH | SVP, Chief Medical Officer | 27 Feb 2024 | Sale | 8,367 | 1.52 | 12,718 | D |
| 29 Feb 2024 18:00 | AKBA | Akebia Therapeutics Inc | BUTLER JOHN P. | CEO and President | 27 Feb 2024 | Sale | 37,733 | 1.52 | 57,354 | D |
| 02 Feb 2024 16:10 | AKBA | Akebia Therapeutics Inc | BUTLER JOHN P. | CEO and President | 01 Feb 2024 | Sale | 46,489 | 1.68 | 78,102 | D |
| 02 Feb 2024 16:10 | AKBA | Akebia Therapeutics Inc | BURKE STEVEN KEITH | SVP, Chief Medical Officer | 01 Feb 2024 | Sale | 24,311 | 1.68 | 40,842 | D |
| 25 May 2023 21:01 | AKBA | Akebia Therapeutics Inc | HADAS NICOLE R. | SVP, Chief Legal Officer | 25 May 2023 | Sale | 63,186 | 1.2229 | 77,270 | D |
| 25 May 2023 21:01 | AKBA | Akebia Therapeutics Inc | DAHAN MICHEL | SVP, Chief Operating Officer | 25 May 2023 | Sale | 95,478 | 1.2229 | 116,760 | D |
| 18 May 2023 18:20 | AKBA | Akebia Therapeutics Inc | BURKE STEVEN KEITH | SVP, Chief Medical Officer | 16 May 2023 | Sale | 63,567 | 1.068 | 67,890 | D |
| 18 May 2023 18:19 | AKBA | Akebia Therapeutics Inc | SPELLMAN DAVID A | SVP, CFO and Treasurer | 16 May 2023 | Sale | 63,567 | 1.068 | 67,890 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)